Exome Sequencing of Consanguineous Pashtun Families With Familial Epilepsy Reveals Causative and Candidate Variants in TSEN54, MOCS2, and OPHN1

Overview

Journal Clin Genet

Specialty Genetics

Date 2024 Oct 14

PMID 39400946

Authors

Afrasiab Khan

Anees Muhammad

Hidayat Ullah

Hina Ambreen

Abeed Ullah

Patrick May

Holger Lerche

Tobias B Haack

Shoaib Ur Rehman

Josua Kegele

Affiliations

Soon will be listed here.

Abstract

Next-generation sequencing is advancing in low- and middle-income countries, but accessibility remains limited. In Pakistan, many members of the Pashtun population practice familial marriage and maintain distinct socio-cultural traditions, isolating them from other ethnic groups. As a result, they may harbor genetic variants that could unveil new gene-disease associations. To investigate the genetic basis of epilepsy in the Pashtun community we recently established a collaboration between Bannu University and the University of Tuebingen. Here we report our first results of exome sequencing of four families with presumed monogenetic epilepsy and Mendelian inheritance pattern. In Family #201, we identified distinct disease-causing variants. One had a homozygous pathogenic missense variant in TSEN54 (c.919G > T, p.(Ala307Ser)), linked to Pontocerebellar Hypoplasia Type 2A. The second individual had a homozygous class IV missense variant in MOCS2 (c.226G > A, p.(Gly76Arg)) which is associated with Molybdenum cofactor deficiency. In family EP02, one affected individual carried a heterozygous class III variant in OPHN1 (c.1490G > A, p.(Arg497Gln)), related to syndromic X-linked intellectual disability with epilepsy. Our small study demonstrates the promise of next-generation sequencing in genetic epilepsies among the Pashtun population. Diagnostic next-generation sequencing should be established in Pakistan as soon as possible, and if not feasible, genetic research projects may pioneer this path.

References

Johannes L, Fu C, Schwarz G . Molybdenum Cofactor Deficiency in Humans. Molecules. 2022; 27(20). PMC: 9607355. DOI: 10.3390/molecules27206896. View

Nadif Kasri N, Nakano-Kobayashi A, Malinow R, Li B, Van Aelst L . The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors. Genes Dev. 2009; 23(11):1289-302. PMC: 2701582. DOI: 10.1101/gad.1783809. View

Namavar Y, Barth P, Kasher P, van Ruissen F, Brockmann K, Bernert G . Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia. Brain. 2010; 134(Pt 1):143-56. PMC: 9136852. DOI: 10.1093/brain/awq287. View

Moortgat S, Lederer D, Deprez M, Buzatu M, Clapuyt P, Boulanger S . Expanding the phenotypic spectrum associated with OPHN1 mutations: Report of 17 individuals with intellectual disability but no cerebellar hypoplasia. Eur J Med Genet. 2018; 61(8):442-450. DOI: 10.1016/j.ejmg.2018.03.002. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Yaqoob M, GUSTAVSON K, Jalil F, Karlberg J, Iselius L . Early child health in Lahore, Pakistan: II. Inbreeding. Acta Paediatr Suppl. 1993; 82 Suppl 390:17-26. DOI: 10.1111/j.1651-2227.1993.tb12903.x. View

Riaz M, Tiller J, Ajmal M, Azam M, Qamar R, Lacaze P . Implementation of public health genomics in Pakistan. Eur J Hum Genet. 2019; 27(10):1485-1492. PMC: 6777461. DOI: 10.1038/s41431-019-0428-z. View

Budde B, Namavar Y, Barth P, Poll-The B, Nurnberg G, Becker C . tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia. Nat Genet. 2008; 40(9):1113-8. DOI: 10.1038/ng.204. View

Hussain M, Razzaq A, Iqbal Z, Shahzad M, Polla D, Song Y . Exome sequencing of Pakistani consanguineous families identifies 30 novel candidate genes for recessive intellectual disability. Mol Psychiatry. 2016; 22(11):1604-1614. PMC: 5658665. DOI: 10.1038/mp.2016.109. View

10.

Samanta D, Willis E . Intractable epileptic spasms in a patient with Pontocerebellar hypoplasia: Severe phenotype of type 2 or another subtype?. Ann Indian Acad Neurol. 2016; 19(3):385-7. PMC: 4980965. DOI: 10.4103/0972-2327.168629. View

11.

Pacheva I, Todorov T, Ivanov I, Tartova D, Gaberova K, Todorova A . Gene-Related Pontocerebellar Hypoplasia Type 2 Could Mimic Dyskinetic Cerebral Palsy with Severe Psychomotor Retardation. Front Pediatr. 2018; 6:1. PMC: 5787054. DOI: 10.3389/fped.2018.00001. View

12.

Vijayakumar K, Gunny R, Grunewald S, Carr L, Chong K, DeVile C . Clinical neuroimaging features and outcome in molybdenum cofactor deficiency. Pediatr Neurol. 2011; 45(4):246-52. DOI: 10.1016/j.pediatrneurol.2011.06.006. View

13.

Nunez-Samudio V, Arcos-Burgos M, Landires I . Rare diseases: democratising genetic testing in LMICs. Lancet. 2023; 401(10385):1339-1340. DOI: 10.1016/S0140-6736(23)00343-4. View

14.

Falb R, Muller A, Klein W, Grimmel M, Grasshoff U, Spranger S . Bi-allelic loss-of-function variants in cause severe fetal akinesia with arthrogryposis multiplex. J Med Genet. 2021; 60(1):48-56. PMC: 9811090. DOI: 10.1136/jmedgenet-2021-108064. View

15.

Smith L, Malinowski J, Ceulemans S, Peck K, Walton N, Sheidley B . Genetic testing and counseling for the unexplained epilepsies: An evidence-based practice guideline of the National Society of Genetic Counselors. J Genet Couns. 2022; 32(2):266-280. DOI: 10.1002/jgc4.1646. View